Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5219_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Contents
- •Editors and Contributors
- •About the Editors
- •Contributors
- •1.1 Introduction
- •1.2 Conventional Methods
- •1.2.1 Microscopy
- •1.2.2 Culture
- •1.2.3 Germ Tube Test
- •1.2.5 Carbohydrate Assimilation Test
- •1.2.6 Nitrogen Assimilation Test
- •1.2.7 Carbohydrate Fermentation Test
- •1.2.8 Urease Test
- •1.2.9 Tween 80 Opacity Test
- •1.3 Nonculture-Based Conventional Methods
- •1.3.1 Serological Methods
- •1.3.1.2 ß-d-Glucan
- •1.3.1.3 C. albicans Germ Tube Antibody Assay (CAGTA)
- •1.4 Nucleic Acid-Based Detection
- •1.4.1 Polymerase Chain Reaction (PCR)
- •1.4.3 Peptide Nucleic Acid FISH (PNA-FISH)
- •1.4.4 PCR-Based Innovative Diagnosis
- •1.4.5 FilmArray System
- •1.4.6 Sepsis Flow Chip
- •1.4.7 ePlex System
- •1.4.8 The T2 Candida Assay
- •1.5 Rapid Identification Systems
- •1.5.1 Manual Rapid Identification System
- •1.5.1.1 The API System
- •1.5.1.2 The VITEK System
- •1.5.2 Automatic Rapid Identification System
- •1.5.2.1 MALDI-TOF MS
- •1.5.2.2 The MALDI Sepsityper IVD Kit
- •1.5.2.3 The BioFire FilmArray BCID2 Panel
- •1.5.2.4 The Accelerate Pheno BC Panel
- •1.6 Advanced Diagnostics
- •1.6.2 Biosensor-Based Tests
- •1.6.3 Next-Generation Sequencing (NGS)
- •1.7 Conclusion
- •References
- •2.1 Introduction
- •2.2.1.2 Echinocandins
- •First-Generation Echinocandin
- •Second-Generation Echinocandin
- •2.2.1.3 Other Cell Wall Inhibitors
- •2.2.2.1 Azoles
- •Imidazole
- •Triazole
- •Second-Generation Azole
- •Third-Generation Azole
- •2.2.2.2 Polyenes
- •Other Polyene Under Development
- •2.2.2.3 Allylamines
- •2.2.3 Flucytosine
- •2.3 Conclusion
- •References
- •3.1 Introduction
- •3.2.1 Control Diet
- •3.2.3 Toxification
- •3.2.4 Alternative Treatments
- •3.3.1 Prophylaxis
- •3.3.2 Preemptive Therapies
- •3.3.3 Empirical Therapies
- •3.4 Therapeutic Approach
- •3.4.1 Azoles
- •3.4.2 Echinocandins
- •3.4.3 Polyenes
- •References
- •4.1 Introduction
- •4.3 Eukarya Domain
- •4.4.1 Cryptococcus
- •4.4.2 Aspergillus
- •4.4.3 Mucorales
- •4.4.4 Candida
- •4.5.1 Candida albicans
- •4.5.2 Morphogenesis
- •4.5.3 Pathogenesis
- •4.5.4 Adherence
- •4.5.5 Morphological Switching
- •4.5.6 Invasion
- •4.6 Induced Endocytosis
- •4.7 Active Penetration
- •4.8.2 Biofilm Formation
- •4.8.4.1 Antifungals
- •4.8.4.2 Antifungal Resistance
- •References
- •5.1 Introduction
- •5.2.3.1 Serum
- •5.2.3.2 Low Nitrogen
- •5.2.3.5 Carbon Source
- •5.2.3.6 pH
- •5.2.3.7 N-acetylglucosamine (GlcNAc)
- •5.2.3.8 Quorum Sensing Molecule
- •5.5.5 Surface Colonization Factor1 (SCF1)
- •5.5.6 Other Putative Adhesins
- •5.6.1 Phospholipases
- •5.6.2 Proteinases
- •5.6.3 Hemolysins
- •5.6.4 Lipases
- •5.7 Secreted Cytolytic Peptide: Candidalysin
- •5.5.1 ALS Family
- •5.5.2 HWP Adhesin
- •5.5.3 HYR/IFF Family
- •5.5.4 EPA Family
- •5.9.2 Low Molecular Weight Hsp/Small Heat Shock Proteins
- •5.10.1 Amino Acid/Nitrogen Metabolism
- •5.10.1.1 Amino Acid Sensing Pathway
- •5.12.1.1 Glycolysis
- •5.12.1.2 Gluconeogenesis
- •5.12.1.3 Glyoxylate Cycle
- •5.12.1.4 Fatty Acid Oxidation
- •5.12.3.2 Iron Metabolism
- •5.12.3.3 Candida Iron Transport
- •5.12.3.4 Reductive System
- •5.12.3.5 Siderophore Uptake System
- •5.12.3.6 Haemoglobin-Iron Uptake System
- •5.13.2 Zinc Metabolism
- •References
- •6.1 Introduction
- •6.2 Morphological Switching
- •6.3 Phenotypic Switching
- •6.4 Biofilm Formation
- •6.5 Metabolic Flexibility
- •6.8.1 Hemolysin
- •6.8.2 Phospholipases
- •6.8.3 Proteinase
- •6.8.4 Candidalysin
- •6.12 Conclusion
- •References
- •7.1 Introduction
- •7.2.4 Polymorphism
- •7.2.5.1 Secreted Aspartyl Proteinases
- •7.2.5.2 Phospholipase
- •7.2.6 Calcineurin-Signalling Pathway
- •7.2.7 Ion Homeostasis
- •7.2.7.1 Iron
- •7.2.7.2 Copper
- •7.2.8.1 Capsule
- •7.2.8.2 Melanin
- •7.2.8.3 Heat Shock Proteins
- •7.3 Conclusions
- •References
- •8.1 Introduction
- •8.4.1 ATP-Binding Cassette (ABC) Transporters
- •8.4.2 Major Facilitator Superfamily (MFS) Transporter
- •8.5.1 Biofilm Architecture Among Candida Species
- •References
- •9.1 Introduction
- •References
- •10.1 Introduction
- •10.3 Biofilm
- •10.5 Adherence
- •10.6 Maturation
- •10.8 Dispersion
- •10.11 Animal Models
- •10.18 Photodynamic Therapy
- •References
- •11.1 Introduction
- •11.9 Concluding Remarks
- •References
- •12.1 Introduction
- •12.2 Epidemiology
- •12.3.1 Humoral Response
- •12.3.2 Cellular Immunity
- •12.4 Virulence Factors
- •12.6.1 Fluconazole
- •12.6.2 Polyenes
- •12.6.3 Echinocandins
- •12.7 Drug Resistance
- •12.8 Future Prospects
- •12.9 Conclusions
- •References
- •13.1 Introduction
- •13.4 Translation Research
- •13.4.1 Disease-Oriented Translational Research
- •13.4.2 Lab-Oriented Translational Research
- •13.4.3 Patient-Oriented Translational Research
- •13.5 Conclusion
- •References
- •14.1 Introduction
- •14.2.3 Cutaneous Aspergillosis
- •14.2.4 Ocular Aspergillosis
- •14.2.5 Aspergillus Endocarditis
- •14.2.6 Aspergillus Osteomyelitis
- •14.2.7 Sinus Aspergillosis
- •14.3.2 Histopathology
- •14.3.3 Serological
- •14.3.4 Breath Testing
- •14.3.5 Monoclonal Antibody (mAbs)-Mediated Methods
- •14.4.1 Conventional Therapeutics
- •14.4.1.1 Azoles
- •14.4.1.2 Polyenes
- •14.4.1.3 Echinocandins
- •14.4.1.4 Fluoropyrimidines
- •14.5 Nonconventional Therapeutics
- •14.5.1 Vaccine
- •14.5.2 Monoclonal Antibodies (mAbs)
- •14.5.3 Nanotechnology-Based Therapeutics
- •14.5.4 Immune Therapy
- •14.5.5 Combination Therapy
- •14.8 Conclusion
- •References
- •15: Aspergillus Therapeutics: Future Agents
- •15.1 Introduction
- •15.2.1 Fosmanogepix
- •15.2.2 Ibrexafungerp
- •15.2.3 Olorofim
- •15.2.4 Opelconazole
- •15.2.5 Rezafungin
- •15.2.6 MGCD290
- •15.2.7 Tetrazoles (VT-1129/VT-1161/VT-1598)
- •15.2.8 Nikkomycin Z
- •15.2.9 VL-2397
- •15.2.10 T-2307/ATI-2307
- •15.2.11 Encochleated Amphotericin-B
- •15.2.12 SUBA-Itraconazole
- •15.2.13 Immunotherapy
- •15.2.14 Drug Repurposing
- •References
- •16.1 Introduction
- •16.2 Antifungal Agents
- •16.2.1 Azoles
- •16.2.2 Posaconazole
- •16.2.3 Isavuconazole
- •16.2.4 SUBA—Itraconazole
- •16.2.5 Nanovoriconazole
- •16.2.6 Adverse Effects
- •16.3 Liposomal Amphotericin B (LAMB)
- •16.3.1 Echinocandins
- •16.4 Combination Antifungal Therapy
- •16.5 Therapeutic Drug Monitoring (TDM)
- •16.5.1 Azole-Resistant Aspergillus Spp.
- •16.6 Guideline Recommendations
- •16.10 Conclusion
- •References
- •17.1 Introduction
- •17.3 Potent Antifungal Molecules Under Investigations
- •References
- •19.2 Host–A. fumigatus Interactions
- •19.3.1 Hydrophobicity or Rodlet Layer
- •19.3.2 Conidiation
- •19.3.3 DHN Melanin
- •19.3.5 Siderophores
- •19.3.6 Biofilm Formation
- •19.4 Conclusion
- •References

9 Biolm Formation inCandida Species
241
and hospital-acquired infections is increasing daily. While Candida is a commensal
in humans, it can transition to a pathogenic phase, especially when an individual is
immunocompromised or when the environment is made conducive for Candida
proliferation, and biolm formation is one of the mechanisms enabling these cells
to survive (Mba and Nweze 2020b).
Various Candida species can cause challenging infections, with Candida albi-
cans being the most prevalent and implicated, followed by Candida glabrata (Mba
and Nweze 2020a, b; Macias-Paz etal. 2023). Candida tropicalis is mostly involved
in urinary tract infections (Rho etal. 2004). On the other hand, Candida parapsilo-
sis is more prevalent in the skin of healthy hosts, leading to catheter-related infections (Yamin et al. 2021; Branco et al. 2023). Each Candida species behaves
differently in their capacity to form a biolm, which largely inuences their morphology. Differences in their extracellular matrix (ECM) production and characteristics also signicantly inuence antifungal resistance patterns (Seneviratne etal.
2008). Despite biolm formation being a common virulence phenotype, the pro-
cesses and factors controlling each step differ from species to species. The nature of
the surface, host niche, and strain-specic factors inuence it. For instance, mature
biolms of C. albicans have a heterogeneous architecture. The blastophores and
hyphae are also surrounded by an ECM (Chandra etal. 2001). The ECM functions
as a structural scaffold. It is involved in adhesion, helping the cell to form a barrier
that offers protection against the surrounding environment (Mitchell etal. 2016).
In contrast, C. glabrata biolms consist exclusively of yeast-form cells. These
cells are arranged, stacked together in a layer form, and tightly clustered (Silva etal.
2009; Rodrigues etal. 2017; Hassan etal. 2021; Malinovská etal. 2023). Biolms
formed by C. tropicalis display yeast, hyphae, and pseudohyphae morphotypes with
well-pronounced hyphal budding (Bizerra etal. 2008). Moreover, in C. parapsilo-
sis, the biolm comprises yeast cell clusters attached to surfaces, having reduced
ECM (Lattif etal. 2010; Malinovská etal. 2023). These differences underscore the
complex processes of biolm formation and the challenge of devising a universal
approach to eradicate Candida infections due to biolm formation. Candida biolms are predominantly found in mucosal or endothelial environments, playing a
critical role in candidiasis. Notably, biolm-associated infections complicate treatment, and implant replacement is unavoidable in most cases. Recently, it has been
estimated that pathogenic biolms are associated with over 80% of all infections
(Schulze etal. 2021; Malinovská etal. 2023). The inherent resilience of microbes
within biolms intensies the difculty in eliminating most infections. Biolm also
signicantly contributes to resistance against antifungal agents (Szekely et al.
2023). These challenges make the treatment of Candida infections progressively
more difcult (Barantsevich and Barantsevich 2022).
Therefore, gaining a thorough understanding of biolm formation in Candida
species is crucial for delineating the factors controlling the process. Developing
means to curtail infections resulting from this virulence phenotype is also important. This chapter focuses on Candida biolms to comprehensively understand the
processes leading to biolm formation and dispersal. This chapter also provided
insight into the mechanisms, transcriptional proteins, and genes controlling biolm

242
Proliferaon
matrix
M. I. Elibe and N. E. Innocent
formation. It also delves into the variations in biolm formation among the Candida
species, while critically discussing biolm regulation. Moreover, how biolm formation contributes to antifungal resistance, especially in mixed-species biolms,
was also discussed.
9.2 Biofilm Formation Process inCandida Species
The major Candida spp. that cause infections include C. albicans, C. tropicalis,
C. glabrata, C. parapsilosis, C. auris, and C. krusei (Malinovská etal. 2023). The
intricate process of biolm formation in all the different species is not completely
well documented, except in C. albicans, which is the major Candida species causing diverse infections and posing therapeutic challenges (Atriwal etal. 2021; Ponde
etal. 2021). Typically, in the initiation stage of biolm formation, the yeast cells
attach to a specic surface, resulting in distinct colony formation (Fig. 9.1).
1
Aachment
(adherence)
Planktonic cells
Biofilm
formaon
4
Dispersal of biofilm
cells
3
Maturaon (formaon of extracellular
Fig. 9.1 Biolm formation process in Candida species
Bioc and abioc surfaces
2

9 Biolm Formation inCandida Species
243
Thereafter, the cells organize themselves and initiate the production and secretion of
extracellular polymeric substances (EPS). The extracellular vesicles play a signicant role in Candida (Karkowska-Kuleta etal. 2023). EPS facilitates the development of a structure, culminating in the recognizable biolm during the maturation
phase. Even after forming a mature biolm, there is the potential for disseminating
progeny biolm cells. During the process, the cells detach from their initial position
and migrate to other locations where they can establish new biolm (Lohse etal.
2018). Interestingly, all these processes are controlled by different factors.
In C. albicans, the initiation stage usually takes about 11h, during which there
are distinct colonies of microcolonies formation. The next phase is characterized by
EPS production. This is followed by bilayer formation. The bilayer is composed of
yeast, germ tubes, and/or young hyphae. Maturation of biolms entails the progression of a substantial extracellular polymeric substance (EPS) layer housing yeasts
and hyphae, constructing a compact interconnected structure within approximately
38–72h. Subsequent to maturation, the dispersal phase ensues. In this stage, fully
developed biolms release offspring cells through budding, transforming into nonadherent yeast cells available for colonization or causing infection, as indicated by
Cámara etal. (2022). Notably, most researches on biolm formation have been carried out under controlled laboratory conditions (in vitro). An informative invivo
investigation by Andes etal. (2004) observed the evolution of C. albicans biolm
within a central venous catheter in rats. This study’s ndings highlighted notable
distinctions compared to experiments conducted in articial environments (in vitro).
For instance, the early phase of invivo biolm formation was shorter, with several
layers of yeast cells and hyphae present after 8h. In contrast, invitro maturation
took 38–72h. In the case of C. glabrata, matured biolm was seen after 48h in
catheters in a rat subcutaneous model. There were also differences in early-phase
development and cell attachment dependence on the catheter. Zuo et al. (2021)
reported that C. parapsilosis had the highest biolm-forming ability among all
Candida species, while C. glabrata had the least. It was also noted that non-albicans
spp., including C. parapsilosis and C. glabrata, had a higher adhesion ability in
catheter-related candidemia. This evidence highlights the increasing role of nonalbicans in clinical infections (Govrins and Lass-Flörl 2023).
Generally, adhesion is the initial and crucial stage of biolm formation. Adhesion
is facilitated by adhesins (proteins associated with cell walls). These adhesins facilitate binding to epithelial cells or nonliving surfaces. The adhesins attach to amino
acids or sugar residues (Gulati and Nobile 2016). Typically, adhesins belong to the
glycosyl-phosphatidylinositol-cell wall proteins. This protein consists of a GPI
anchor and different domains enhancing attachment to carbohydrates or peptides
(Verstrepen and Klis 2006; Kumari etal. 2021). In C. albicans and other Candida
spp., there are the agglutinin-like sequence proteins (Als). The Als is a subset of the
GPI_CWP family. This family comprises several adhesins playing diverse roles in
biolm formation. For example, deletion of Als3 results in a signicant loss of
biolm- forming ability (Nobile etal. 2006). Similar ALS-like proteins are found in
other Candida species. For example, similar Als have been reported in Candida spp.
such as C. tropicalis, C. parapsilosis, C. lusitaniae, C. dubliniensis, and C.

244
M. I. Elibe and N. E. Innocent
guilliermondii (de Groot etal. 2013; Malinovská etal. 2023), though their specic
roles remain largely unknown. Another signicant adhesin family in albicans is the
hyphal wall protein (Hwp). Like Als, there are different members of Hwp, each
playing a different or multiple roles in biolm formation. For example, Hwp1, a
mannoprotein, contributes to biolm formation, as a study by Modrezewka and
Kurnatowski (2015) reported. Other members of the Hwp family (Ywp1, Rbt1,
Hwp2, and Eap1) are also essential for biolm development (de Groot etal. 2013).
In C. glabrata, several adhesins, including Awp14, have been reported to be involved
in biolm formation (Fernández-Pereira etal. 2021). Additionally, in C. parapsilo-
sis, increased expression of adhesins results in higher biolm formation (MorenoMartínez etal. 2021).
Following adhesion, regulated by numerous genes and transcriptional factors,
biolm development progresses through morphological changes. At this stage, there
is an increase in the number of cell numbers. This stage is followed by ECM production. A study on biolm formation and ECM production in C. albicans, C. gla-
brata, C. parapsilosis, and C. tropicalis from various sources reveals species-specic
differences in biolm formation (Estivill etal. 2011; Cavalheiro and Teixeira 2018).
C. albicans biolms, for example, demonstrate greater conuence than those of
other Candida species. It displays various morphologies in infected tissues. Some
of the morphologies include budding and septate hyphae. There was also pseudohyphae formation. On plastic coverslips, C. albicans biolms exhibit a dense network
of yeasts and lamentous cells enclosed in ECM (Ramage etal. 2002). In contrast,
C. glabrata biolms, as mentioned earlier, feature an ECM rich in carbohydrates
and proteins (Silva etal. 2009). Conversely, the biolm structure of C. parapsilosis,
although variable among strains, typically includes pseudohyphae and yeast morphotypes. They form stacked multilayer cell aggregates. The extracellular matrix
produced by C. parapsilosis biolms is predominantly composed of carbohydrates
with low protein composition (Silva etal. 2009). Despite C. tropicalis biolms having a matrix low in carbohydrate and protein content, they exhibit increased resistance to detachment from surfaces compared to biolms formed by C. albicans
(Al-Fattani and Douglas 2006). In a study by Kuhn, most Candida species generally
exhibit a high ability to form biolm, except C. tropicalis (Kuhn etal. 2002a). This
early study suggests that certain cell lineages have more propensity to form biolm
than others.
The biolm structural architecture relies on the production of ECM.The ECM
confers a gel-like structure to the biolm. ECM serves various functions, including
defense against phagocytosis. They provide a scaffold for biolm integrity. This
scaffold makes it difcult for drugs to penetrate. The production of ECM exhibits
variation based on species and strain, nutrient availability, and medium ow rate.
C. tropicalis, for instance, is recognized for its higher ECM production compared to
C. glabrata. In the study by Al-Fattani and Douglas (2006), an increased medium
ow rate was reported to enhance ECM production signicantly. Generally, the
ECM of Candida biolms is primarily composed of polysaccharides, although the
proportions may vary among species (Al-Fattani and Douglas 2006; Balducci etal.
2023). Major carbohydrates in C. tropicalis and C. albicans biolms include

9 Biolm Formation inCandida Species
245
glucose and hexosamine. Uronic acid, phosphorus, and proteins are also present in
smaller amounts. Zarnowski etal. (2014) offered valuable insights into the C. albi-
cans biolm matrix, identifying different macromolecular components and their
contributions to the biolm.
In summary, a diverse array of architectures, adhesion properties, cellular mor-
phologies, and ECM compositions characterize Candida biolms. These characteristics are not only specic to each species. In some instances, it also depends on the
strain. Additionally, external factors in the biolm’s surrounding environment play
a crucial role in shaping the nal biolm produced (Toyofuku etal. 2016; Yin etal.
2019; Mirghani etal. 2022).
9.3 Regulation ofBiofilm Formation inCandida Species
Saccharomyces cerevisiae and C. albicans diverged over a million years ago.
However, over the years, S. cerevisiae has been well-studied, with several studies
shedding light on its genetic and genomic composition. Among all the Candida species, C. albicans is the most studied. However, there is less information on its
genetic manipulation as compared to S. cerevisiae. C. albicans face challenges in
genetic tractability due to complexities in its parasexual cycle, especially under
laboratory conditions (Mba etal. 2022). Despite these constraints, several emerging
tools have helped to genetically manipulate C. albicans, providing a wealth of information on its biology and genomic composition. So far, recombinant DNA technologies and whole genome sequencing platforms have been pivotal in deciphering
the complexity of biolm formation in pathogenic fungi. About 1000 gene knockout
mutants have been successfully created. This value is out of approximately 6000
total genes. This has enabled screening and identifying different biolm phenotypes, thus providing the foundation for uncovering genes and regulatory proteins
involved in biolm formation. Moreover, proteomics and transcriptional proling
have also been critical in uncovering proteins and genes involved in biolm formation in pathogenic fungi. With all these available tools, it is now widely clear that
about six complex transcriptional networks control the biolm development of
C. albicans. They include Tec1, Bcr1, Efg1, Ndt80, Rob1, and Brg1. These genes
are regulators and, as such, control a wide range of downstream genes. They directly
bind to and likely regulate more than 1000 genes. Some of these target genes are
extra-transcriptional regulators. The entire connection forms an interconnected network of genes involved in forming biolm.
Genes playing roles in biolm formation differ, and some play interwoven roles
or similar roles. While specic genes act as adhesins to control hyphae production,
ECM production, and drug resistance, some genes play dual or multiple roles.
Despite identifying numerous target genes in the biolm network, many of the
genes remain unstudied and yet to be properly characterized. Based on orthology
mapping, there is an evolutionary hint that C. albicans’ biolm-forming ability has
evolved recently. This insight explains why C. albicans and their near neighbor are
among the few fungal species capable of forming biolms within a human host.

246
M. I. Elibe and N. E. Innocent
Although there is incomplete insight into the mechanistic pathways controlling biolm, it is now relatively easy to investigate biolm formation in a wide range of
cells and also study genes with nonregulatory functions and their roles in biolm
formation. Besides the already described biolm master regulators, about 44 extra
regulators have been uncovered and associated with biolm. These regulators, when
deleted, affected the formation of biolms by Candida spp.
Interestingly, most of these additional regulators are linked with the master regu-
lator. This evidence suggests potential direct regulation by the core biolm circuit
(Gulati and Nobile 2016; Rodriguez etal. 2020). While the transcriptional factors
control biolm formation, it has also been shown that they also regulate pseudohyphal growth. They are also associated with how cells respond to osmotic stress (Ni
etal. 2009). Evidence is also available that they are pivotal in white-opaque celltype switching in C. albicans (Hernday etal. 2013).
Most of the transcriptional factors are associated with hyphal formation, adhe-
sion, and ECM production. Identifying the intricate regulatory network underlying
biolm formation holds great promise for identifying optimal targets to address
Candida species’ biolm formation. Nobile etal. conducted a study that involved
the construction of about 165 deletion mutants in C. albicans. These mutants were
defective in biolm formation potential both invivo and invitro. Mutants defective
in biolm were associated with bcr1, efg1, brg1, tec1, ndt80, and rob1. Using chromatin immunoprecipitation-on-chip analysis, it was evident that there was a substantial overlap in the mutual control of biolm and the target genes (Nobile etal.
2013). Efg1 and Cph1, two genes involved in biolm formation in C. albicans, also
play a role in lamentous growth. They play a more signicant role during hyphal
differentiation. Notably, the two genes positively inuence the gene expression controlling hyphal growth. They inuence ECE1, ALS3, HWP1, and HYR1 (Hoyer
etal. 1998; Maiti etal. 2015; Malinovská etal. 2023). Deletion mutants Δefg1 and
Δefg1Δcph1 are unable to undergo lamentation or biolm development. The
mutants form only a sparse monolayer of adherent elongated cells (Ramage
etal. 2002).
Furthermore, the Ndt80in C. albicans is implicated in overseeing lamentous
growth, biolm formation, resistance to azole, cell separation, and virulence (Sellam
etal. 2009, 2010). Similarly, Brg1 plays a role related to controlling genes related
to the growth of hyphae in albicans (Cleary etal. 2012). Bcr1, a C2H2 zinc nger
transcription regulator, is also a regulator of biolm. It plays a more prominent role
during the adhesion phase. It inuences surface protein expression. This, in turn,
controls the adhesion of cells during the early stages of the biolm process. When
Bcr1 was knocked out in a rat catheter model, the Candida cell was unable to form
a biolm after 48h. However, this condition was restored by the overexpression of
ALS3 (Lane etal. 2001a, b). Tye7, Cst6, and Ace2 have also been associated with
biolm formation in Candida spp. (Nobile et al. 2008; Cavalheiro and Teixeira
2018). Ace2 homologs in C. glabrata and C. parapsilosis are also signicantly
involved in the formation of biolm (Kamran etal. 2004). C. glabrata possesses
specic transcriptional factors that regulate biolm formation. They employ subtelomeric silencing to control gene expression. However, multiple genes and factors

9 Biolm Formation inCandida Species
247
are involved in biolm in C. glabrata, as noted in research carried out in different
regions (Purohit and Gajjar 2022; Raj etal. 2022; Vázquez-Franco etal. 2022; Zhao
etal. 2022; Huang et al. 2023). Moreover, autophagy has been documented as a
regulator of biolm in Candida albicans (Liu etal. 2022). In addition, recent transcript proling also revealed the role of PDB1, a pyruvate dehydrogenase complex,
in the formation of biolm in C. albicans (Rai etal. 2023). Additional genes and
transcriptional factors governing biolm formation in Candida species are detailed
in Table9.1.
In conclusion, considering the multifaceted aspects of biolms, their regulatory
processes are intricately complex. It encompasses cell adhesion control, formation
of hyphae, extracellular matrix production, dispersal, and various other stages.
Identifying a universal regulator that governs biolm formation across all Candida
species presents a formidable challenge. But such a universal regulator could be an
excellent therapeutic target covering all the Candida spp.
Table 9.1 Genes and transcriptional factors involved in biolm formation (Wheeler etal. 2008;
Homann etal. 2009; Finkel etal. 2012; Fox etal. 2015; Araújo etal. 2017; Cavalheiro and Teixeira
2018; Pokhrel etal. 2022; Gulati and Nobile 2016; Xu etal. 2022; McCall etal. 2019; Rodriguez
etal. 2020; Liu etal. 2022)
Gene name Description
Als
Als1-7,9.
Als1,3 and 5
Others include: Ecm33, Eap1, Msb2, Hwp1,
Mp65, Pbr1, and Pga1,
Hwp
Hwp1, Hwp2, and Rbt1, Try2-7
Brg1, Rob1, Tec1 and Ndt80 Facilitates hyphal formation
Csh1, Adh5, Adh1, Xog1, Bgl2, Gca1, Gca2,
Gsc1, Phr1, and Ifd6, Rlm1
Rlm1 Positively regulate extracellular matrix
Zap1 Negatively regulate extracellular matrix
Nrg1, Pse1 Involved in increasing biolm dispersal
Ume6 Involved in the reduction of biolm
Hsp90, Hos2, Sif2, Pes1, Set3, Ywp1 and Snt1 Also involved in dispersal
Bcr1 and Bcr1 Play a role in adhesion and lamentation
Flo8 Filamentation
Rfx2, Zcf8,28,31,32,34,39, Ace2,Ada2,Ahr1,
Arg81,Rfg1, Efg1
Ume6, Nrg1 Filamentation and dispersal
Large cell surface glycoproteins involved
in attachment
Mostly involved in the attachment process
Required for adhesion, cell aggregation,
and hyphal formation
Involved in extracellular matrix production
production.
production.
when overexpressed
dispersal when overexpressed
Regulate Hwp1 expression
Filamentation and adhesion

248
M. I. Elibe and N. E. Innocent
9.4 Multispecies Biofilm Between Candida Species
andOther Microbes
Most times, infections are conceptualized and addressed as if a singular microbe is
operating independently. However, infections transpire within the context of the
human microbiota. This encompasses a diverse array of microbes inhabiting the
body. Understanding biolm formation and considering the presence of other
microbial members within a niche are crucial. C. albicans is the most implicated
pathogenic fungi, causing infections, especially in immunocompromised patients.
However, various Candida spp. have been identied alongside C. albicans in polymicrobial biolms and coinfections. These species include C. dubliniensis, C. gla-
brata, C. tropicalis, C. parapsilosis, C. guillermondii, C. krusei, and C. auris
(Pathak etal. 2012; Ponde etal. 2021). Coinfection between Candida species and
other Candida species (Silva etal. 2011; Yazdanpanah et al. 2023) and bacteria–
Candida coinfection also pose more treatment difculty (Jenkinson and Douglas
2002; Fourie and Pohl 2019; Haiko etal. 2019; Salvatori etal. 2020). In vitro stud-
ies indicate that bacterial species and Candida spp. interact in diverse ways from
various locations. These interactions inuence biolm formation. However, our
understanding of how Candida spp. interacts both within themselves and together
with other microbes is largely limited. A study by Witchley etal. (2019) showed that
the morphogenesis of C. albicans inuences microbiota balance and composition,
thus demonstrating how Candida spp. can inuence nearby microbial communities.
A more recent study by Eichelberger and Cassat (2021) revealed the metabolic patterns during coinfection between C. albicans and S. aureus. According to the results,
alterations in metabolism control the severity of infection during coinfection. There
was an increase in the production of toxins in S. aureus, which plays a role in morphogenesis and cell wall modication in C. albicans. Additionally, polymicrobial
biolms formed by C. albicans and S. aureus exhibit increased biomass and
decreased susceptibility to antifungals compared to biolms produced by single
cells. During coinfection, the metabolic processes triggered in S. aureus and C. albi-
cans inuence their interactions with host immune cells, leading to enhanced microbial survival and evasion of the immune response.
So far, not much has been learned about dual-species biolms between C. albi-
cans and other microbes. Studies have explored such biolms, pairing C. albicans
with bacteria frequently isolated from different human body. Some of these microbes
secrete signaling molecules, directly or indirectly inuencing polymicrobial infection. A recent study by Lueyar etal. (2023) provided a deep insight into Candida
interaction with streptococcus species in oral biolm. The study suggests that
S. mutans and S. gordonii prompt the production of lamentous structures in C. albicans. The bacteria impact decreases the counts of C. albicans. The interaction
between S. mutants and C. albicans in biolm was also recently studied by Xiao
etal. (2022). From the study, it was observed that interactions between different
kingdoms inuence the initiation and production of biolms. It was also noted to
inuence the dynamic expression of virulence genes in S. mutans and C. albicans.
Pseudomonas aeruginosa produces a 12-carbon acyl homoserine lactone. This

9 Biolm Formation inCandida Species
compound controls the growth of hyphae in C. albicans (Lindsay and Hogan 2014).
C. albicans biolms can also create a hypoxic microenvironment, thus supporting
anaerobic bacteria growth (Nobile and Johnson 2015). The interactions within
diverse microbes in polymicrobial biolms and their implications for health are
undeniably of considerable interest and signicance. Humans create a diverse
microbial environment. The microbiome of humans includes members from different life forms (viruses, fungi, bacteria, and archaea). These different microbial
forms maintain a symbiotic relationship, bringing about complexity within the ecosystem. Genetic or environmental factors could disrupt the ecosystem, including
changes in pH, shifts in immunity, the indiscriminate use of broad-spectrum antimicrobials, and changes in nutrient composition within a niche. Such disruption could
lead to infections resulting from the overgrowth of certain lineages more adapted to
environmental changes.
Candida albicans, a prevalent fungal pathogen, commonly engages in commen-
salism with bacteria. Establishing a clinical prognosis for polymicrobial interactions in individuals, especially in immunocompromised individuals, is challenging.
This is due to their heightened vulnerability to other infections. This makes assessing the extent of these interactions and molecular mechanisms difcult. More study
is therefore needed to understand the interaction between Candida biolm and other
microbial pathogens.
249
9.5 Biofilm Formation, Persister Cells, andAntifungal
Resistance inCandida Species
The increasing resistance to antifungals among most pathogenic fungi poses a
growing public health concern, as highlighted by recent studies (Kaur and Nobile
2023; Vitiello etal. 2023). This threat is not conned to specic regions but extends
globally. It affects various nations, including low and middle-income countries
(Ambe etal. 2020; Codda etal. 2023; Díaz-García etal. 2023; Freitas etal. 2023;
Sathi etal. 2023). While different mechanisms are responsible for Candida resistance to antifungals (Bhattacharya etal. 2020; Czajka etal. 2023), the development
of resistance is closely linked to the formation of biolms. This has been shown in
a study that reported that C. albicans biolms, after 48h, were more than eight
times more resistant to all antifungals than non-biolm-forming cells (Hawser and
Douglas 1995). Similarly, C. parapsilosis biolms displayed heightened resistance
to various antifungals, including amphotericin B, uconazole, voriconazole,
nystatin, and several other antifungals (Kuhn etal. 2002a, b). Several factors contribute to the increased resistance observed during Candida biolm growth. These
factors include elevated metabolic activity during the initial process of biolm
(Ramage etal. 2005; Desai and Mitchell. 2015).
The ECM may also inuence antifungal drug resistance. It has been proposed
that it acts as a barrier, enhancing Candida cells’ resistance to drugs like amphotericin B (Lucas and Silva 2023; Massey etal. 2023). Upregulation of MDR and CDR
genes in C. alibicans brings about changes in the expression of genes involved in

250
M. I. Elibe and N. E. Innocent
biolm formation. These genes encode azole-resistance transporters (Shi et al.
2019; Costa-de-Oliveira and Rodrigues 2020). In C. glabrata that forms biolms,
TPO1-2, CDR1, and CDR2 gene overexpression has been observed. TPO1-2 is
involved in resistance to antifungal. It is also crucial for the expression of adhesionrelated genes (Song etal. 2009; Pais etal. 2016; Santos etal. 2017). Indeed, C. gla-
brata biolms have been demonstrated to exhibit signicantly higher resistance to
antifungals than planktonic cells (Song etal. 2009; Seneviratne etal. 2010).
Moreover, akin to observations in other microorganisms, persister cells exist
within C. albicans biolms. The identication of persisters in Candida species has
been associated with biolms that remain unaffected by antifungals (Denega etal.
2019). These dormant, nondividing cells display signicant resistance to antimicro-
bial drugs. This attribute is due to their dormancy, which helps to prevent drugs
from getting to their targets (Lewis 2007). Persister cells within biolms demonstrate resistance to antifungals (e.g., uconazole). When the cells are grown within
a biolm, they also exhibit elevated expression of CDR genes (Wuyts etal. 2018).
Numerous uncertainties persist regarding Candida persister cells. Understanding
biolm plasticity and the role of persister cells in persistent infections is critical. In
bacterial persister research, microuidics tools have been utilized to identify and
isolate persister cells by assessing the cell population that survives antibiotic treatment and resumes growth after antibiotic removal. A similar approach could be
applied to study fungal persister cells. Such a study could potentially open avenues
for discovering novel antifungal candidates and developing newer drugs. So far,
knowledge about fungal persister cells is limited. Moreover, there are no treatment
options to eliminate fungal biolms completely. However, the successful eradication of persister cells, as seen in some investigations (Galdiero etal. 2020), offers
optimism. It suggests that in the future, fungal biolms may also be eradicated.
9.6 Conclusion andPerspective
This chapter underscores the complex processes occurring within cells that lead to
the formation of Candida biolms. It has been established that the biolm formation process includes adhesion, cell morphology changes, ECM formation, and biolm dispersal. Notably, factors that control each of these steps are species- or
strain-specic in most cases. Several factors, including nutrient composition, inhibitors within a niche, environmental conditions, and microbiome in an environment,
impact the ultimate characteristics of the biolm. Despite the existing knowledge,
many aspects, particularly those related to biolm formation among non-Candida
albicans cells, remain inadequately explored. Unfortunately, most non-albicans are
posing major public health threats due to their frequent isolation and link to most
infectious diseases. It is crucial to differentiate between biolms formed by diverse
Candida spp., especially the non-albicans. It is also important to understand the
biolm forms by commensal Candida populations. Understanding how this Candida
population transitions to pathogens exhibiting biolm-forming propensity demands
Соседние файлы в папке Библиотека им академика М.И. Перельмана
